Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Nutrition & Diabetes|June 11, 2024
L-valine is a powerful stimulator of GLP-1 secretion in rodents and stimulates secretion through ATP-sensitive potassium channels and voltage-gated calcium channelsIda Marie Modvig, Mark M Smits, Katrine Douglas Galsgaard, et al.
British Journal of Clinical Pharmacology|November 27, 2015
Exenatide acutely increases heart rate in parallel with augmented sympathetic nervous system activation in healthy overweight malesMark M Smits, Marcel H A Muskiet, Lennart Tonneijck, et al.
The Lancet. Diabetes & Endocrinology|May 7, 2015
Pleiotropic effects of type 2 diabetes management strategies on renal risk factorsMarcel H A Muskiet, Lennart Tonneijck, Mark M Smits, et al.
Frontiers in Endocrinology|April 8, 2024
Indole-3-carboxyaldehyde does not reverse the intestinal effects of fiber-free diet in miceMark M Smits, Serafina I L Dreyer, Jenna E Hunt, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 25, 2015
GLP-1 Receptor Agonist Exenatide Increases Capillary Perfusion Independent of Nitric Oxide in Healthy Overweight MenMark M Smits, Marcel H A Muskiet, Lennart Tonneijck, et al.
Diabetes, Obesity & Metabolism|June 2, 2020
Effects of dipeptidyl peptidase-4 inhibitor linagliptin versus sulphonylurea glimepiride on systemic haemodynamics in overweight patients with type 2 diabetes: A secondary analysis of an 8-week, randomized, controlled, double-blind trialJordan Kraaijenhof, Marcel H A Muskiet, Lennart Tonneijck, et al.
Diabetes Research and Clinical Practice|December 3, 2014
Uncomplicated human type 2 diabetes is associated with meal-induced blood pressure lowering and cardiac output increaseMark M Smits, Marcel H A Muskiet, Maarten E Tushuizen, et al.
Pancreas|September 28, 2010
Nonalcoholic fatty liver disease is related to nonalcoholic fatty pancreas diseaseErwin-Jan M van Geenen, Mark M Smits, Tim C M A Schreuder, et al.
Journal of the American Society of Nephrology : JASN|February 2, 2017
Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and TreatmentLennart Tonneijck, Marcel H A Muskiet, Mark M Smits, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 27, 2016
GLP-1-Based Therapies Have No Microvascular Effects in Type 2 Diabetes Mellitus: An Acute and 12-Week Randomized, Double-Blind, Placebo-Controlled TrialMark M Smits, Lennart Tonneijck, Marcel H A Muskiet, et al.
Pageof 7